No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 Trial.
Demolder A, O'Neill L, El Haddad M, Scherr D, Vijgen J, Wolf M, Berte B, Bisbal F, Johannessen A, Rivero-Ayerza M, De Potter T, De Becker B, Polain de Waroux JL, Knecht S, Tavernier R, Duytschaever M.
Demolder A, et al. Among authors: de becker b, de potter t.
Circ Arrhythm Electrophysiol. 2023 Nov;16(11):e012043. doi: 10.1161/CIRCEP.123.012043. Epub 2023 Nov 3.
Circ Arrhythm Electrophysiol. 2023.
PMID: 37921006
Free article.
Clinical Trial.